VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
62 hedge funds and large institutions have $151M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 14 closing their positions.
Holders
62
Holders Change
+13
Holders Change %
+26.53%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
11
Reduced
12
Closed
14
Calls
$885K
Puts
$961K
Net Calls
-$76K
Net Calls Change
-$201K
Top Buyers
1 |
1
BlackRock
New York
|
$23.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$16.3M |
3 |
3
State Street
Boston,
Massachusetts
|
$5.49M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$5.09M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$3.55M |